Stock ZYME ZYMEWORKS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Zymeworks Inc.

Equities

ZYME

US98985Y1082

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-01 EDT 		5-day change 1st Jan Change
8.76 USD +2.10% Intraday chart for Zymeworks Inc. +2.46% -15.69%
04-08 Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting CI
04-04 Zymeworks Inc. Removes Christopher Astle from the Positions of Chief Financial Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Unlocking the potential of antibody drug conjugates
AQ
Zymeworks Announces Participation in Upcoming Investor Conferences
GL
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PR
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
GL
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
GL
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PR
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GL
Zymeworks Announces Participation in Upcoming Investor Conferences
GL
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
GL
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
AQ
Zymeworks Announces Participation in Upcoming Investor Conferences
GL
Zymeworks Announces Participation in Upcoming Investor Conferences
AQ
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
GL
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
AQ
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
GL
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
AQ
Zymeworks Announces Participation in Upcoming Investor Conferences
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYME Stock
  4. News Zymeworks Inc.
  5. Press Releases